136 related articles for article (PubMed ID: 10385756)
1. Heart failure: A case for subspecialized care management.
Smith JJ; Konstam MA
Am Heart J; 1999 Jul; 138(1 Pt 1):14-6. PubMed ID: 10385756
[No Abstract] [Full Text] [Related]
2. Beta-blockers - again, a lesson to us all, especially the research funding community.
Coats AJ
Int J Cardiol; 2000 Apr; 73(2):103-4. PubMed ID: 10817846
[No Abstract] [Full Text] [Related]
3. The impact of angiotensin-converting enzyme inhibitors on managed care: economic, clinical, and humanistic outcomes.
Reeder CE; Gourley GA; Wurtzbacher JD; Reed P
Am J Manag Care; 2000 Feb; 6(3 Suppl):S112-28, quiz S129-31. PubMed ID: 10977441
[TBL] [Abstract][Full Text] [Related]
4. AstraZeneca's investment in landmark trials in heart failure.
Cardiovasc J S Afr; 2002; 13(1):38-40. PubMed ID: 11998800
[No Abstract] [Full Text] [Related]
5. Pharmacologic management of heart failure and left ventricular systolic dysfunction: effect in female, black, and diabetic patients, and cost-effectiveness.
Shekelle P; Morton S; Atkinson S; Suttorp M; Tu W; Heidenreich P; Gubens M; Maglione M; Jungvig L; Roth E; Newberry S
Evid Rep Technol Assess (Summ); 2003 Jul; (82):1-6. PubMed ID: 14571595
[No Abstract] [Full Text] [Related]
6. Cost of medical services in older patients with heart failure: those receiving enhanced monitoring using a computer-based telephonic monitoring system compared with those in usual care: the Heart Failure Home Care trial.
Soran OZ; Feldman AM; Piña IL; Lamas GA; Kelsey SF; Selzer F; Pilotte J; Lave JR
J Card Fail; 2010 Nov; 16(11):859-66. PubMed ID: 21055649
[TBL] [Abstract][Full Text] [Related]
7. The European Society of Cardiology (ESC) Annual Meeting 2005.
von Haehling S
Heart Fail Monit; 2005; 4(4):150-2. PubMed ID: 16234901
[No Abstract] [Full Text] [Related]
8. Higher expectations for management of heart failure: current recommendations.
Abraham WT; Scarpinato L
J Am Board Fam Pract; 2002; 15(1):39-49. PubMed ID: 11841137
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
[TBL] [Abstract][Full Text] [Related]
10. [Economic significance of heart failure. An overview of costs and economics of therapy].
Szucs TD; Sokolovic E
Herz; 2000 Aug; 25(5):538-46. PubMed ID: 10993002
[TBL] [Abstract][Full Text] [Related]
11. A management programme for suspected heart failure in primary care in cooperation with specialists in cardiology.
Mejhert M; Kahan T
Eur J Gen Pract; 2015 Mar; 21(1):26-32. PubMed ID: 25342003
[TBL] [Abstract][Full Text] [Related]
12. Management of patients with heart failure: are internists as good as cardiologists?
Bonarjee VV; Dickstein K
Eur Heart J; 2001 Apr; 22(7):530-1. PubMed ID: 11259139
[No Abstract] [Full Text] [Related]
13. [Contemporary approaches to diagnosis and management of chronic heart failure (summary of the American College of Cardiology/American Heart Association Guidelines)].
Sidorenko BA; Preobrazhensky DV; Batyraliev TA; Marenitch AV; Romanova NE
Kardiologiia; 2002; 42(6):65-78. PubMed ID: 12494135
[TBL] [Abstract][Full Text] [Related]
14. The effects of angiotensin receptor antagonists on mortality and morbidity in heart failure--and an interaction with beta blockade.
Coats AJ
Int J Cardiol; 2001 Jan; 77(1):1-4. PubMed ID: 11150619
[No Abstract] [Full Text] [Related]
15. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.
Cole JA; Norman H; Weatherby LB; Walker AM
Pharmacotherapy; 2006 Aug; 26(8):1157-64. PubMed ID: 16863491
[TBL] [Abstract][Full Text] [Related]
16. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Angiotensin-converting enzyme inhibitors in the management of congestive heart failure: a pharmaceutical industry perspective.
Boccuzzi SJ
Am Heart J; 1999 May; 137(5):S120-2. PubMed ID: 10220612
[No Abstract] [Full Text] [Related]
17. Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs.
Skrepnek GH; Abarca J; Malone DC; Armstrong EP; Shirazi FM; Woosley RL
Ann Pharmacother; 2005 Nov; 39(11):1785-91. PubMed ID: 16219900
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of heart failure based on large-scale clinical trials: renin-angiotensin system antagonists and beta-blockers].
Kubota T; Takeshita A
Nihon Rinsho; 2003 May; 61(5):801-6. PubMed ID: 12755006
[TBL] [Abstract][Full Text] [Related]
19. Beta blockers in systolic heart failure.
Jackowski L; Azam R
Aust Fam Physician; 2008 Mar; 37(3):137-9. PubMed ID: 18345362
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first?
Fang JC
Circulation; 2005 Oct; 112(16):2380-2. PubMed ID: 16230494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
